ArticleScientific reports2025
Effect of temperature on structural properties and antibacterial performance of Fe-Co-Al@BTC MOF: A molecular docking and computational perspective.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Engineering Metal-Organic Frameworks with Ag, Zn, and Cu for Enhanced Antimicrobial Efficacy: From Fundamentals to Antibacterial Strategies, and Challenges.Biological trace element research · 2026Review
- Design, synthesis, and anticancer evaluation of a novel imine-linked covalent organic framework correlated to molecular docking and DFT insights.RSC advances · 2026Article
- High-performance Fe-Al@BTC MOF for supercapacitor and antibacterial applications: experimental, DFT, and molecular docking studies.Scientific reports · 2026Article
- Multifunctional pectin derivatives as anticancer agents in colorectal cancer via synthesis, computational insights, and modulation of NRF2/HO-1, HIF-1α, and VEGF/PDGF-D signaling pathways.Scientific reports · 2026Article
- Concept of 2D van der Waals Nanohybrids for Key Biomedical Applications.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, the impact of temperature on metal-organic framework (Fe-Co-Al @BTC) structural properties and antibacterial activity was investigated. It was synthesized by both hydrothermal method and at room temperature. It exhibited remarkable differences in crystallinity, porosity, morphology, and antibacterial activity. Fe-Co-Al@BTC prepared at room temperature exhibited higher crystallinity, larger average particle size, distinct morphology, and enhanced antibacterial activity compared to the hydrothermally synthesized sample. The estimated optical band gap was found to be ~ 2.48 eV and 2.25 eV for MOF synthesized at room temperature and hydrothermal conditions, respectively which was confirmed by PL results. Antibacterial performance, evaluated using optical density measurements and the cut plug method, demonstrated 100% bacterial growth inhibition at 600 mg/L for the room temperature sample, whereas the hydrothermal sample showed 50% inhibition at the same concentration. Density functional theory (DFT) calculations with the LANL2DZ basis set revealed the MOF's electronic and photocatalytic properties, indicating stability, moderate reactivity, and potential for photocatalytic applications through analysis of the HOMO-LUMO gap and metal-to-ligand charge transfer. Thermodynamic analysis indicated that room temperature synthesis is more favorable despite slower crystallization, while hydrothermal synthesis is faster but energetically more demanding. Both syntheses were exothermic; however, higher temperature reduces spontaneity due to entropic penalties, with Gibbs free energy confirming room-temperature synthesis as the preferred approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.